How Abbott’s Newest Indication Is Reshaping Heart Failure Management
The company has won a new indication for the CardioMems Sensor to be implanted in NYHA Class II patients.
The company has won a new indication for the CardioMems Sensor to be implanted in NYHA Class II patients.